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Cleft lip with or without cleft palate (CL/P) is a complex trait with evidence that the clinical spectrum includes both microform and
subepithelial lip defects. We identiﬁed missense and nonsense mutations in the BMP4 gene in 1 of 30 cases of microform clefts, 2 of
87 cases with subepithelial defects in the orbicularis orismuscle (OOM), 5 of 968 cases of overt CL/P, and 0 of 529 controls. These results
provide conﬁrmation that microforms and subepithelial OOM defects are part of the spectrum of CL/P and should be considered during
clinical evaluation of families with clefts. Furthermore, we suggest a role for BMP4 in wound healing.Isolated clefts of the lip with or without cleft palate (CL/P
[MIM 119530]) comprise about 70% of all children born
with an orofacial cleft. Cases of overt CL/P display a range
of severity, from notches in the vermillion to complete
bilateral clefts of the lip and palate.1,2 Also observed are
more subtle expressions of the CL/P phenotype that are
sometimes termed ‘‘microforms’’ and typically involve
small defects of the lip, alveolar arch, or scar-like ridges
above the lip.3,4 Such microforms extend to the muscle
ﬁbers of the superior orbicularis oris muscle (OOM).5,6
Microform cleft lip (congenital healed cleft lip [MIM
600625]) is a rarely reported birth defect that is suggested
to occur in 0.06 /10,000 live births.7 Even more subtle
than the visible microforms are subepithelial defects
of the OOM. Martin et al.8 observed such defects in
18-week-old fetuses and developed a method to visualize
OOM defects by using ultrasonography.9 A signiﬁcant
increase in the frequency of OOM defects has been
reported in people who are related to individuals with
CL/P but who do not have overt clefts.9 The fact that sub-
epithelial defects of the OOM are part of the spectrum of
orofacial cleft expression was also conﬁrmed by Neis-
wanger et al.10 Furthermore, histologic studies of OOMs
visualized as abnormal by ultrasound showed both disor-406 The American Journal of Human Genetics 84, 406–411, March 1ganized OOM ﬁbers and excess connective tissue in
comparison to normal OOMs.11
Informative mouse models for cleft lip and cleft palate
have aided the search for genes involved in human
CL/P12–14, as have rareMendelian CL/P forms that are close
phenocopies of isolated CL/P.15,16 The current study was
motivated by a mouse model in which a conditional
knockout for Bmp4 (MIM112262) had an unusual ‘‘healed’’
cleft-lip phenotype17; Liu et al.17,18 found that all embryos
had bilateral cleft lip at 12 days after conception but that by
14.5 days only 22% still exhibited cleft lip. They hypothe-
sized that many of the initial cleft lips had healed in utero.
In this report we evaluate the BMP4 gene in individuals
born with overt CL/P, microform CL/P, and subepithelial
OOM defects.
Clinical aspects of the sample collection have been
described elsewhere.10,19,20 The University of Iowa Institu-
tional Review Board (IRB) gave approval for sample collec-
tion (approval numbers 199804081, 200003065, and
200109094) in conjunction with local approval in the
Philippines, Colombia, and Children’s Hospital and
Regional Medical Center, Seattle, Washington. The Ohio
State University approved sample collection in Ohio
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Figure 1. Subepithelial and Microform
Defects
Ultrasound Images of the Proband S91C,
Who Has an Orbicularis Oris Muscle Defect,
and Her Husband
Ultrasound images are taken in the
transverse plane; the top of the image
corresponds to anterior structures; OOM ¼
orbicularis oris muscle; AR¼ alveolar ridge.
The arrowhead in (A) points to the discon-
tinuity in the OOM of the proband (A). In
contrast, note the continuous appearance
of the husband’s OOM (B). (C) A child
(A346V) has left microform CLP. (D) His
father (A346V) has subtle right microform
cleft lip and a ‘‘heart-shaped’’ bifid uvula.
See Table S1 for a summary of the cases
and controls sequenced for BMP4.approved sample collection in Pittsburgh, Spain,
Guatemala, and the Philippines (approval numbers
0405013, 0511198, and 0607057) after approval by the
IRBs of the local sites. The ethics committee of the School
of Dentistry, Aichi-Gakuin University, approved the
sample collection in Mongolia (approval number 11) in
conjunction with local approval in Mongolia. DNA
samples from 30 individuals with microform cleft lip
(27 Filipinos, two Americans, and one Colombian), from
87 cases with OOM defects (nine Filipinos, 31 Americans,
34 Guatemalans, and 13 Europeans), from 968 cases with
overt CL/P (537 Filipinos and 431 Mongolians) and from
529 controls (345 Filipinos, 90 Mongolians, and 94 Euro-
peans) were sequenced according to published protocols.16
Five primer pairs (Table S2) were used for examining all
four BMP4 exons and 50 bp of ﬂanking sequence
(NP_001193). M.L.M., A.C.L., A.H., A.R.V., J.C.M., or
S.D.H. reviewed subjects with CL/P to exclude any with
syndromic features. OOM defects were assessed by high-
resolution ultrasound according to the methods of Neis-
wanger et al.10 (Figures 1A and 1B). Note that all cases
and controls are unrelated; only one cleft or OOM defect
case was taken from any particular family.
Table S1 in the Supplemental Data summarizes the
origins of the cases and controls studied. The mutations
identiﬁed in the cases and their relatives are provided in
Table S2 and depicted in Figure 2. No mutations were
found in the controls. Five of the total 968 cases (0.51%)
with overt nonsyndromic CL/P were found to have previ-
ously unreported missense or nonsense mutations. Two
of the total 87 cases with OOM defects and one of the
30 cases with microform CL/P had novel missense muta-
tions. One common missense-encoding SNP (p.A152V,
c.455 C > T, SNP rs17563) was found in both cases and
controls, with a borderline-signiﬁcant difference inThe Amefrequency (the frequency of the C allele for the case and
control is 0.20 and 0.26, respectively, and that for the
T allele for the case and control is 0.80 and 0.74, respec-
tively) (p ¼ 0.04).
Differences between groups were assessed with Fisher’s
exact tests (see Web Resources). The frequency of BMP4
mutations was greater for all cases (overt CL/P plus micro-
forms plus OOM defects) than for all controls (8/1085 ¼
0.74% versus 0/529 ¼ 0%) but was not statistically signif-
icant (p ¼ 0.06). Notably, the BMP4 mutation frequency
for overt CL/P cases alone was not signiﬁcantly greater
than for controls (5/968 ¼ 0.52% versus 0/529, p ¼
0.17), whereas the frequency for microform plus OOM
cases was signiﬁcantly greater than for controls (3/117 ¼
2.56% versus 0/529, p ¼ 0.006). Furthermore, the BMP4
mutation frequency in overt CL/P cases was signiﬁcantly
less than the frequency in microform plus OOM cases
(5/968 versus 3/117, p ¼ 0.04).
Comparative amino acid sequence analysis (Figure 2)
showed complete conservation of the amino acid sequence
in eight species (human, chimpanzee, cow, rat, dog,
chicken, frog, and zebraﬁsh) at positions p.S91C (c.271
A > T), p.R162Q (c.485 G > A), p.R287H (c.860 G > A),
and p.A346V (c.1037 C > T). The missense mutation S91C
was predicted to be possibly damaging by POLYPHEN (see
Web Resources)21, and the R162Q and A346V variants are
predicted to be intolerant amino acid changes by SIFT
(see Web Resources).22 In addition, one nonsense muta-
tion, p.R198X (c.592 C> T), was identiﬁed. Themicroform
case with the missense mutation A346V is shown along
with his son in Figures 1C and 1D. The father (1D) has
a biﬁd uvula (MIM 192100) and microform cleft lip and
the son with the same mutation has a microform cleft
lip and a cleft palate. Two other cases with missense
mutations (S91C and R287H) were parents who hadrican Journal of Human Genetics 84, 406–411, March 13, 2009 407
Figure 2. Comparative Amino Acid Sequence Alignment of Vertebrate BMP4 and Mutations of BMP4 in Humans
The top row shows a schematic diagram of the human BMP4 gene with the positions of exons and their translated protein domains. Both
exon 3 and exon 4 are in the translated region. Filled green is the TGF beta propeptide domain and violet is the TGF beta domain.
Gray background in the alignment indicates regions of complete amino acid identity across species. Comparative amino acid alignment
follows the order of Homo sapiens (Human [NP_001193]), Pan troglodytes (Chimpanzee [XP_509954]), Bos taurus (Cow
[NP_001039342]), Rattus norvegicus (Rat [NP_036959]), Canis familiaris (Dog [XP_851628]), Gallus gallus (Chicken [NP_990568]), Xen-
opus tropicalis (Frog [NP_001017034]), and Danio rerio (Zebrafish [NP_571417]). C is Cleft lip and palate; oo is orbicularis oris defect; M is
Microform cleft.OOM defects only and a child who had unilateral cleft lip
and palate and who had the same mutation as the affected
parent. The OOM defect for the S91C variant is shown in
Figure 1A. The SIFT intolerant amino acid change,
R162Q, was found in a child with cleft lip and palate
who had a father with the R162Q variant. The father
himself, diagnosed as unaffected by routine clinical obser-
vation, did not have an ultrasound evaluation. Each of the
parent-to-child transmissions has amore severe phenotype
in the child, which is suggestive of anticipation, but the
numbers are small and the cases biased in ascertainment
so that these ﬁndings are only suggestive of an increase
in severity with each passing generation.
Three other variants were identiﬁed. The ﬁrst, V152A, is
a previously reported SNP (rs17563).We found a borderline
difference in case and control frequencies for this SNP, and
a recent report has shown a frequency difference for the
same associated allele in a Chinese cleft population23 con-
sisting of 184 cases and 205 controls. The second variant,408 The American Journal of Human Genetics 84, 406–411, March 1p.G168A (c.503 G > C), was seen in a proband with cleft
lip and palate and in a clinically unaffected mother who
did not have an OOM ultrasound evaluation. The third
variant, p.T102A (c.304 A > G), was seen in two patients
with cleft lip and palate (one Filipino and oneMongolian).
In both families, one parent of the case had the T102A
variant and no overt cleft but did not have an OOM ultra-
sound (summarized in Table S2).
In this report a mutation search within BMP4 in cases
with overt CL/P, microforms, and subepithelial OOM
defects found that 3 of 117microform or OOMdefect cases
had a missense mutation predicted to be disruptive by
in silico protein modeling. This was also observed in 5 of
968 overt CL/P cases, whereas no mutations were found
in 529 controls. In three of the OO/microform cases, the
mutations identiﬁed segregated from a parent with an
OOM defect or microform to a child with an overt cleft.
The frequency of BMP4 mutations in microform and
OOM defect cases was signiﬁcantly higher than in controls3, 2009
(p ¼ 0.006), but the frequency in overt CL/P cases did not
reach signiﬁcance (p ¼ 0.17).
A recent report demonstrates that disruptions in BMP4
and Hedgehog signaling result in craniofacial develop-
mental anomalies of the brain, eye, and digits (MCOPS6
[MIM 607932]).24 They demonstrate ocular clefting-like
phenotypes (coloboma [MIM 120200]) in some cases and
found both frameshift and missense BMP4 mutations
that generate a more severe and general phenotype than
the mutations reported here. In addition both SHH [MIM
600725]25 and PTCH1 [MIM 601309]26 have been associ-
ated with clefting in mice and humans.
The results reported here are consistent with ﬁndings in
the Bmp4 mouse model17,18, suggesting either that amino
acid alterations in BMP4 result in delayed lip closure (result-
ing in the appearance of a healed scar) or that actual healing
of the cleft has occurred through an unknownmechanism.
The mouse model is a conditional knockout of craniofacial
tissues and so is not directly analogous to the heterozygous
amino acid variants observed here, but the striking pheno-
typic overlap of the unusual clinical appearances adds
support to the connections between the genotypes and
phenotypes observed. Bmp signaling has been implicated
in dorsal closure in Drosophila, a model system for wound
healing. Our ﬁnding that BMP4 has a role in microform
and subepithelial clefting is consistentwith the speculation
that a conserved genetic pathway might be involved in
both wound healing and CL/P.27 Identifying factors that
modulate wound healing in the embryo would afford
opportunities both for identiﬁcation of groups at high risk
for poor wound healing (where surgical approaches or
timingmight be inﬂuenced) and for the use of these factors
to enhance the wound repair itself.
It can be difﬁcult to prove that any particular rare variant
observed is etiologic in a complex trait unless those vari-
ants are strong candidates on the basis of expression and
arise de novo, as was seen in a recent report suggesting
that spontaneous mutations in VANGL1 (MIM 610132)
could be a risk factor for neural-tube defects (NTD [MIM
182940]).28 Kryukov29 has provided empiric evidence
that about 70% of missense mutations present at popula-
tion frequencies of 1% or less probably contribute to the
phenotype in which they are ﬁrst identiﬁed. Identifying
eight such rare missense variants in this cleft-related popu-
lation (and identifying none in controls) would mean that
there is a probability of more than 99.9% that at least one
of these variants contributes to clefting . A range of other
genes has been reported in which rare missense or
nonsense mutations also appear to contribute to isolated
CL/P.12–14,16,30–32 In this report we found a signiﬁcant
overrepresentation of BMP4 mutations in cases with a
range of lip and OOM defects and an absence of such vari-
ants in more than 500 control samples. These ﬁndings
support a role for BMP4 in the pathogenesis of isolated
CL/P and/or in wound healing.
Furthermore, our observation that amino acid variations
in BMP4 are associated with microform and subepithelialThe AmeOOM defects provides conﬁrmation that such subtle
defects are part of the clinical spectrum of CL/P. Given
that children with overt clefts had parents with microform
cleft or OOM defects, genetic evaluation and counseling
might now beneﬁt from a full family phenotypic evalua-
tion assessing such minor forms of clefts and including
a high-resolution ultrasound of the upper-lip OOM. Muta-
tions in BMP4 should therefore be considered in any family
whose non-overt-cleft members exhibit microform clefts
or OOM defects. Prospective evaluation of the impact of
these and other subclinical phenotypes on the occurrence
of cleft lip and palate will increasingly be important in
genetic counseling of nonsyndromic orofacial cleft fami-
lies.33
Supplemental Data
Supplemental Data include two tables and are available with this
article online at http://www.ajhg.org/.
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Note Added in Proof
In the version of this paper published online on February 26, the
legend of Figure 2 contained descriptions for panels A and B,
although no such panels were included in the ﬁgure. The legend
has since been corrected online and in print through the
removal of these panel labels. No additional text changes were
made.rican Journal of Human Genetics 84, 406–411, March 13, 2009 411
